-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$16.2138.9% Upside
Roivant Sciences Ltd. Frequently Asked Questions
-
What analysts cover Roivant Sciences Ltd.?
Roivant Sciences Ltd. has been rated by research analysts at Leerink Partners, Goldman Sachs, Bank of America Securities, Piper Sandler, H.C. Wainwright, Deutsche Bank in the past 90 days.